Advanced BioPhotonics Completes $2 Million Financing.BOHEMIA, N.Y. -- Advanced BioPhotonics Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : ABPH ABPH American Board of Psychological Hypnosis (Beverly, MA) ABPH Associated British Ports Holdings PLC (UK) ABPH Able Seaman Photographer ) a developer of next generation medical imaging applications using advanced infrared technology announced today that it has closed on a $2 million financing with institutional investors. The terms of the financing are disclosed in a Form 8-K filing made with the Securities and Exchange Commission on November 3, 2006. Denis Denis, king of Portugal: see Diniz. O'Connor, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Advanced BioPhotonics, commented "We are very pleased that our investors continue to support the company in its efforts to commercialize its technology. While our technology platform has promise in a multitude of applications, we continue to focus on applications with the nearest term commercialization opportunities. We believe that with this additional financing, the company will be able to make significant progress towards commercialization." About Advanced BioPhotonics Advanced BioPhotonics Inc. (OTCBB: ABPH) headquartered in Bohemia, New York Bohemia is a hamlet (and census-designated place) in Suffolk County, New York, United States. The population was 9,871 at the 2000 census. Bohemia is in the Town of Islip. , is an innovative developer of medical imaging applications using advanced infrared technology. Advanced BioPhotonics provides imaging technology for clinicians and researchers for use in the detection and management of diseases affecting perfusion or reperfusion re·per·fu·sion n. The restoration of blood flow to an organ or tissue that has had its blood supply cut off, as after a heart attack. of tissue or organs. Advanced BioPhotonics's mission is to improve the quality and cost-effectiveness of healthcare services and research through identifying, acquiring and adapting high-resolution infrared technology for biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. applications. For more information about the Company and its technology, please visit http://www.advancedbp.com/. This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, the ability of the Company to develop effective new products and receive governmental approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion